{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:40:56Z","timestamp":1761043256238,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.urolonc.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T19:06:14Z","timestamp":1637348774000},"page":"65.e11-65.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subsequent primary urogenital cancers among childhood and adolescent cancer survivors in the United States"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7379-5022","authenticated-orcid":false,"given":"Jason J.","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculata","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2021.10.009_bib0001","first-page":"143","article-title":"Genetic factors contribute to subsequent neoplasms in survivors of childhood cancer","volume":"70","author":"Fillon","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.urolonc.2021.10.009_bib0002","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamaoncol.2019.5582","article-title":"Life expectancy of adult survivors of childhood cancer over 3 decades","volume":"6","author":"Yeh","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0003","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2016.05.006","article-title":"Long-term risk of renal and urinary tract diseases in childhood cancer survivors: a population-based cohort study","volume":"64","author":"Bonnesen","year":"2016","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2021.10.009_bib0004","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.10.009_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/pbc.21826","article-title":"Late effects on the urinary bladder in patients treated for cancer in childhood: a report from the children's oncology group","volume":"52","author":"Ritchey","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.urolonc.2021.10.009_bib0006","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.6004\/jnccn.2018.7023","article-title":"Management of primary ovarian insufficiency symptoms in survivors of childhood and adolescent cancer","volume":"16","author":"Gargus","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.urolonc.2021.10.009_bib0007","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","article-title":"Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review","volume":"53","author":"Overbeek","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"10.1016\/j.urolonc.2021.10.009_bib0009","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jc.2003-030352","article-title":"Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer","volume":"88","author":"Larsen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"10.1016\/j.urolonc.2021.10.009_bib0010","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.10.009_bib0011","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1634\/theoncologist.2017-0201","article-title":"Ovarian and uterine functions in female survivors of childhood cancers","volume":"23","author":"Oktem","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.urolonc.2021.10.009_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.fertnstert.2018.10.016","article-title":"Uterine function, pregnancy complications, and pregnancy outcomes among female childhood cancer survivors","volume":"111","author":"van de Loo","year":"2019","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.urolonc.2021.10.009_bib0013","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1530\/REP-18-0221","article-title":"How does chemotherapy treatment damage the prepubertal testis?","volume":"156","author":"Allen","year":"2018","journal-title":"Reproduction"},{"issue":"32","key":"10.1016\/j.urolonc.2021.10.009_bib0014","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1200\/JCO.19.00738","article-title":"Leydig cell function in male survivors of childhood cancer: a report from the St Jude lifetime cohort study","volume":"37","author":"Chemaitilly","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.10.009_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1464-410X.2010.09224.x","article-title":"Risk of bladder tumours after childhood cancer: the British childhood cancer survivor study","volume":"106","author":"Frobisher","year":"2010","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2021.10.009_bib0016","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.juro.2015.06.092","article-title":"Risk of a second kidney carcinoma following childhood cancer: role of chemotherapy and radiation dose to kidneys","volume":"194","author":"de Vathaire","year":"2015","journal-title":"J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.10.009_bib0017","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jnci\/djt014","article-title":"Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study","volume":"105","author":"Wilson","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"31","key":"10.1016\/j.urolonc.2021.10.009_bib0018","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2015.60.9487","article-title":"Risk of subsequent neoplasms during the fifth and sixth decades of life in the childhood cancer survivor study cohort","volume":"33","author":"Turcotte","year":"2015","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.urolonc.2021.10.009_bib0019","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0020","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program. Characteristics of the SEER population compared with the total United States population. Accessed from: http:\/\/seer.cancer.gov\/registries\/characteristics.html. Accessed at: October 3, 2021."},{"key":"10.1016\/j.urolonc.2021.10.009_bib0021","series-title":"International classification of diseases for oncology (ICD-O-3)","first-page":"1","author":"Percy","year":"2000"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102881","article-title":"Gender-dependent radiotherapy: the next step in personalised medicine?","volume":"147","author":"De Courcy","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0023","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Quality Improvement. Accessed from: https:\/\/seer.cancer.gov\/qi\/. Accessed at: October 3, 2021."},{"issue":"2","key":"10.1016\/j.urolonc.2021.10.009_bib0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.urolonc.2009.11.005","article-title":"Surveillance Epidemiology and End Results (SEER) program and population-based research in urologic oncology: an overview","volume":"30","author":"Scosyrev","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2021.10.009_bib0025","unstructured":"United States Census Bureau. Current population survey (CPS) historical migration\/geographic mobility tables. Accessed from: https:\/\/www.census.gov\/data\/tables\/time-series\/demo\/geographic-mobility\/historic.html. Accessed at: October 3, 2021."},{"issue":"12","key":"10.1016\/j.urolonc.2021.10.009_bib0026","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","article-title":"Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the childhood cancer survivor study cohort","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921004774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921004774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:18Z","timestamp":1761042258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921004774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1078143921004774"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.10.009","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subsequent primary urogenital cancers among childhood and adolescent cancer survivors in the United States","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}